These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 24485450)

  • 1. Progeria: a paradigm for translational medicine.
    Gordon LB; Rothman FG; López-Otín C; Misteli T
    Cell; 2014 Jan; 156(3):400-7. PubMed ID: 24485450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicine. Mouse study suggests cancer drugs could help prematurely aging kids.
    Travis J
    Science; 2006 Feb; 311(5763):934-5. PubMed ID: 16484462
    [No Abstract]   [Full Text] [Related]  

  • 3. The posttranslational processing of prelamin A and disease.
    Davies BS; Fong LG; Yang SH; Coffinier C; Young SG
    Annu Rev Genomics Hum Genet; 2009; 10():153-74. PubMed ID: 19453251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rejuvenating premature aging.
    Meshorer E; Gruenbaum Y
    Nat Med; 2008 Jul; 14(7):713-5. PubMed ID: 18607367
    [No Abstract]   [Full Text] [Related]  

  • 5. Blocking protein farnesylation improves nuclear shape abnormalities in keratinocytes of mice expressing the prelamin A variant in Hutchinson-Gilford progeria syndrome.
    Wang Y; Ostlund C; Worman HJ
    Nucleus; 2010; 1(5):432-9. PubMed ID: 21326826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of progeria-like disease phenotypes in knock-in mice expressing a non-farnesylated version of progerin.
    Yang SH; Chang SY; Ren S; Wang Y; Andres DA; Spielmann HP; Fong LG; Young SG
    Hum Mol Genet; 2011 Feb; 20(3):436-44. PubMed ID: 21088111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamin A-linked progerias: is farnesylation the be all and end all?
    Smallwood DT; Shackleton S
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):281-6. PubMed ID: 20074075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular insights from a premature aging syndrome: a translational story.
    Nabel EG
    Trans Am Clin Climatol Assoc; 2012; 123():221-5; discussion 225-6. PubMed ID: 23303987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progeria: case report and new drugs perspectives.
    Grana AG; Silva AA; Moura Filho FR; Rodrigues Ferreira Rocha de Alencar R; Chicre Bandeira de Melo P
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e293-e294. PubMed ID: 29377371
    [No Abstract]   [Full Text] [Related]  

  • 10. A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria.
    Fong LG; Frost D; Meta M; Qiao X; Yang SH; Coffinier C; Young SG
    Science; 2006 Mar; 311(5767):1621-3. PubMed ID: 16484451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progeria, the nucleolus and farnesyltransferase inhibitors.
    Mehta IS; Bridger JM; Kill IR
    Biochem Soc Trans; 2010 Feb; 38(Pt 1):287-91. PubMed ID: 20074076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective.
    Cau P; Navarro C; Harhouri K; Roll P; Sigaudy S; Kaspi E; Perrin S; De Sandre-Giovannoli A; Lévy N
    Semin Cell Dev Biol; 2014 May; 29():125-47. PubMed ID: 24662892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A-type lamins and progeroïd syndromes : persistent farnesylation with dramatic effects].
    Navarro CL; Poitelon Y; Lévy N
    Med Sci (Paris); 2008 Oct; 24(10):833-40. PubMed ID: 18950579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.
    Liu GH; Barkho BZ; Ruiz S; Diep D; Qu J; Yang SL; Panopoulos AD; Suzuki K; Kurian L; Walsh C; Thompson J; Boue S; Fung HL; Sancho-Martinez I; Zhang K; Yates J; Izpisua Belmonte JC
    Nature; 2011 Apr; 472(7342):221-5. PubMed ID: 21346760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prelamin A prenylation and the treatment of progeria.
    Worman HJ
    J Lipid Res; 2010 Feb; 51(2):223-5. PubMed ID: 19965579
    [No Abstract]   [Full Text] [Related]  

  • 16. Embryonic senescence and laminopathies in a progeroid zebrafish model.
    Koshimizu E; Imamura S; Qi J; Toure J; Valdez DM; Carr CE; Hanai J; Kishi S
    PLoS One; 2011 Mar; 6(3):e17688. PubMed ID: 21479207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlights of the 2007 Progeria Research Foundation scientific workshop: progress in translational science.
    Gordon LB; Harling-Berg CJ; Rothman FG
    J Gerontol A Biol Sci Med Sci; 2008 Aug; 63(8):777-87. PubMed ID: 18772465
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapamycin activates autophagy in Hutchinson-Gilford progeria syndrome: implications for normal aging and age-dependent neurodegenerative disorders.
    Graziotto JJ; Cao K; Collins FS; Krainc D
    Autophagy; 2012 Jan; 8(1):147-51. PubMed ID: 22170152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear localization signal deletion mutants of lamin A and progerin reveal insights into lamin A processing and emerin targeting.
    Wu D; Flannery AR; Cai H; Ko E; Cao K
    Nucleus; 2014; 5(1):66-74. PubMed ID: 24637396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZMPSTE24, an integral membrane zinc metalloprotease with a connection to progeroid disorders.
    Barrowman J; Michaelis S
    Biol Chem; 2009 Aug; 390(8):761-73. PubMed ID: 19453269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.